Nevro Stock Price - NVRO

139.00
0.00 (0.00%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Nevro Corp NVRO NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
6.54 4.94% 139.00 137.70 148.05 141.00 132.46 17:15:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
12,941 892,475 $ 142.22 $ 126,927,197 395,289 42.82 - 148.05
Last Trade Time Type Quantity Stock Price Currency
18:30:00 34,679 $ 139.00 USD

Nevro Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.31B 31.01M $ -49.21M -1.63 -34.14 29.99M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.45M $ - 0.00% - -

more financials information »

Nevro News

Loading Messages....

Latest NVRO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NVRO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week143.08148.05130.48139.00343,881-4.08-2.85%
1 Month135.69148.05130.48138.50311,4193.312.44%
3 Months113.32148.05107.05124.04371,82525.6822.66%
6 Months83.13148.0575.20106.14382,20355.8767.21%
1 Year43.72148.0542.8281.33448,96395.28217.93%
3 Years98.55148.0534.7571.65510,42540.4541.05%
5 Years43.25148.0534.7570.32481,31395.75221.39%

Nevro Description

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.


Your Recent History
NYSE
NVRO
Nevro
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.